Personalized Pathway-Activated Systems Imaging in Oncology

Principal and Instrumentation

Häftad, Engelska, 2018

1 202 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt över 249 kr.

Beskrivning

This comprehensive volume covers radiopharmaceuticals developed for pathway-directed systems in imaging and theranostic applications.

Produktinformation

Utgivningsdatum:2018-08-08
Mått:155 x 235 x 14 mm
Vikt:440 g
Format:Häftad
Språk:Engelska
Antal sidor:243
Förlag:Springer Verlag, Singapore
ISBN:9789811098505

Utforska kategorier

Onkologi inom Medicin
Nuklearmedicin inom Medicin

Mer om författaren

Dr. Tomio InouePresident, Yokohama City University Medical Center Dr. David J. YangProfessor and Section Chief, Radiotheranostic Section,Department of Cancer System Imaging,Division of Diagnostic Imaging,MD Anderson Cancer Center,Consultant and Professor at The University of Tennessee Health Science Center,Vice-president for Vyripharm Biopharmaceuticals Dr. Gang HuangChairman, Institute of Nuclear Medicine,Shanghai JiaoTong University School of Medicine

Innehållsförteckning

Part 1: Chemical Biology Aspect.- Chapter 1: PET Radiotracers for Tumor Imaging (Ming Rong Zhang).- Chapter 2. Theranostic tracers for pathway-activated systems in oncology (Lan V. Pham, Jerry L. Bryant, David Yang, and Richard J. Ford).- Chapter 3. Optimization of Aseptic Production in PET Radiopharmaceuticals for Compliance to the Most Current GMP (Chih-Hao K. Kao) - Part 2: Engineering and Instrumentation Aspect.- Chapter 4. OpenPET enabling PET imaging during radiotherapy (Taiga Yamaya and Hideaki Tashima).- Chapter 5. High Resolution PET/CT development (Wai-Hoi Wong, and Yuxuan Zhang).- Part 3: Social Aspect.- Chapter 6. Ethics, Regulations and Clinical Development of Precision Medicine: Activating with molecular imaging (Chieko Kurihara, and Tomio Inoue).- Chapter 7. Optical Imaging: How far can we go (Wenbin Ma, Sara Herrera-Rodriguez, and Hector Martinez-Valdez).- Part 4: Clinic Aspect.- Chapter 8. Applications of UIH High Resolution PET/CT in Zhongshan Hospital (Jun Zhou, Hongcheng Shi).- Chapter 9. Clinical evaluation of focused high-resolution breast PET (Kanae Kawai Miyake, Yuji Nakamoto).- Chapter 10. Recent Developments with Large-bore PET/CT (Tomohiro Kaneta, Tomio Inoue).- Chapter 11. Copper-labeled radiopharmaceuticals in oncology (Hiroaki Kurihara).- Chapter 12. PET radiopharmaceuticals in oncology beyond FDG (Shao-Li Song, Pan-Li Li, Gang Huang).- Chapter 13. Molecular Imaging in Oncology: Challenges and Opportunities in 21st Century (Ya-Ming Li, Ya-Ming Li, David J. Yang, and Xue-Na Li).- Chapter 14. Visualization of Apoptosis: Annexin V imaging (Skye Hsin-Hsien Yeh, Fan-Lin Kong, Ming-Hsien Lin).